Try the modernized ClinicalTrials.gov beta website. Learn more about the modernization effort.
Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Malaria in Strasbourg University Hospital (ACMUS)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03594084
Recruitment Status : Unknown
Verified July 2018 by University Hospital, Strasbourg, France.
Recruitment status was:  Recruiting
First Posted : July 20, 2018
Last Update Posted : September 17, 2018
Sponsor:
Information provided by (Responsible Party):
University Hospital, Strasbourg, France

Study Description
Go to 
Top of Page Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information
Brief Summary:
The primary purpose is to describe the anamnestic, clinical, biological, and therapeutic characteristics of imported malaria in people originated from endemic areas. Indeed, clinicians have observed that people from such areas start malaria just after their arrival in France. Such observation needed to be confirmed. In addition, The investigators observed a variation in the laboratory diagnostic performance of malaria between hospital and private laboratories. Such observation also needed to be analyzed objectively

Condition or disease
Malaria

Study Design
Go to 
Top of Page Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information

Layout table for study information
Study Type : Observational
Estimated Enrollment : 70 participants
Observational Model: Case-Only
Time Perspective: Retrospective
Official Title: Retrospective Clinical Study of Malaria in Strasbourg University
Actual Study Start Date : August 1, 2018
Estimated Primary Completion Date : August 2019
Estimated Study Completion Date : August 2019

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Malaria

Groups and Cohorts
Go to 
Top of Page Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information


Outcome Measures
Go to 
Top of Page Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information

Primary Outcome Measures :
  1. Study of clinical characteristics of imported malaria in people originated from endemic areas hospitalized at Strasbourg University Hospital from 2017 to 2018. [ Time Frame: The period from January 1st, 2017 to January 1st, 2018 will be examined ]

Eligibility Criteria
Go to 
Top of Page Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   Child, Adult, Older Adult
Sexes Eligible for Study:   All
Sampling Method:   Non-Probability Sample
Study Population
iagnosis patients with malaria from 01/01/2017 to 01/01/2018
Criteria

Inclusion Criteria:- Patient over 18 years

  • Patients from birth to 18 years
  • Patient submitted to guardianship
  • Patient submitted to trusteeship
  • Diagnosis patients with malaria from 01/01/2017 to 01/01/2018
  • Patient or legal representative agree to use medical data for this research

Exclusion Criteria:

  • Lack of confirmation malaria diagnosis
  • Impossibility to inform patients
  • Patient who does not wish to participate in the study
  • Patient submitted to justice safeguarding
Contacts and Locations
Go to 
Top of Page Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03594084


Contacts
Layout table for location contacts
Contact: Xavier ARGEMI, MD 33 3 69 55 11 87 xavier.argemi@chru-strasbourg.fr
Contact: Anne DINDOYAL, MD 33 3 69 55 11 87 anne.dindoyal@chru-strasbourg.fr

Locations
Layout table for location information
France
Service de Maladies Infectieuses et Tropicales Recruiting
Strasbourg, France, 67091
Contact: Xavier ARGEMI, MD    33 3 69 55 11 87    xavier.argemi@chru-strasbourg.fr   
Contact: Anne DINDOYAL, MD    33 3 69 55 11 87    anne.dindoyal@chru-strasbourg.fr   
Principal Investigator: Xavier ARGEMI, MD         
Sub-Investigator: Anne DINDOYAL, MD         
Sponsors and Collaborators
University Hospital, Strasbourg, France
Investigators
Layout table for investigator information
Study Director: Xavier ARGEMI, MD University Hospital, Strasbourg, France
More Information
Go to 
Top of Page Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information
Layout table for additonal information
Responsible Party: University Hospital, Strasbourg, France
ClinicalTrials.gov Identifier: NCT03594084    
Other Study ID Numbers: 7084
First Posted: July 20, 2018    Key Record Dates
Last Update Posted: September 17, 2018
Last Verified: July 2018

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No
Keywords provided by University Hospital, Strasbourg, France:
Malaria
Malaria imported cases
Recurrent malaria
 Endemic malaria areas
Biological diagnosis
Hospital vs private laboratory diagnosis
Additional relevant MeSH terms:
Layout table for MeSH terms
Malaria
Protozoan Infections
Parasitic Diseases
Infections
Vector Borne Diseases